Last reviewed · How we verify
Unity Health Toronto — Portfolio Competitive Intelligence Brief
12 marketed
0 filed
1 Phase 3
5 Phase 2
1 Phase 1
Live · 30-min refresh
Portfolio leaders (marketed + Phase 3 / filed)
| Drug | Generic | Phase | Class | Target | Area | First approval |
|---|---|---|---|---|---|---|
| furosemide administration | furosemide administration | marketed | Loop diuretic | Na-K-2Cl cotransporter (NKCC2) | Cardiovascular | |
| Zoloft (antidepressant) | Zoloft (antidepressant) | marketed | Selective serotonin reuptake inhibitor (SSRI) | Serotonin transporter (SERT) | Psychiatry / Neurology | |
| Whole Blood | Whole Blood | marketed | ||||
| Semaglutide Pen | Semaglutide Pen | marketed | ||||
| Oxygen + Midazolam | Oxygen + Midazolam | marketed | Supportive care combination (oxygen + benzodiazepine) | GABA-A receptor (midazolam component) | Anesthesia/Procedural Sedation | |
| Nitrous Oxide 99 % | Nitrous Oxide 99 % | marketed | Inhalational anesthetic | NMDA receptor | Anesthesia | |
| Meropenem Infusion | Meropenem Infusion | marketed | Carbapenem antibiotic | Penicillin-binding proteins (PBPs) | Infectious Disease | |
| Withdrawal of furosemide | Withdrawal of furosemide | marketed | Cardiovascular | |||
| Saliva collection | Saliva collection | marketed | ||||
| Rectal Methadone administer during spinal surgery | Rectal Methadone administer during spinal surgery | marketed | ||||
| Nitrous oxide gas for inhalation | Nitrous oxide gas for inhalation | marketed | Dissociative anesthetic | NMDA receptor | Anesthesia and Acute Pain Management | |
| Topical timolol maleate | Topical timolol maleate | marketed | Beta-adrenergic antagonist | Beta-1 and beta-2 adrenergic receptors | Ophthalmology |
Therapeutic area mix
- Cardiovascular · 3
- Anesthesia and Acute Pain Management · 1
- Anesthesia/Procedural Sedation · 1
- Infectious Disease · 1
- Oncology · 1
- Ophthalmology · 1
- Anesthesia · 1
- Psychiatry / Neurology · 1
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Competitive overlap (companies sharing drug classes)
- Assistance Publique - Hôpitaux de Paris · 3 shared drug classes
- University of Florida · 2 shared drug classes
- Policlinico Casilino ASL RMB · 2 shared drug classes
- Second Affiliated Hospital, School of Medicine, Zhejiang University · 2 shared drug classes
- Sunnybrook Health Sciences Centre · 2 shared drug classes
- Bayer · 1 shared drug class
- B&A Therapeutics · 1 shared drug class
- Aspirus Heart and Vascular Institute-Research and Education · 1 shared drug class
Subscribe to ongoing alerts
Every new pipeline event for Unity Health Toronto:
- Unity Health Toronto pipeline updates — RSS
- Unity Health Toronto pipeline updates — Atom
- Unity Health Toronto pipeline updates — JSON
Cite this brief
Drug Landscape (2026). Unity Health Toronto — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/unity-health-toronto. Accessed 2026-05-16.